发明名称 METHOD OF TREATING PAIN UTILIZING CONTROLLED RELEASE OXYMORPHONE PHARMACEUTICAL COMPOSITIONS AND INSTRUCTION ON DOSING FOR RENAL IMPAIRMENT
摘要 The invention pertains to a method of using oxymorphone in the treatment of pain by providing a patient with an oxymorphone dosage form and informing the patient or prescribing physician that the bioavailability of oxymorphone is increased in patients with renal impairment.
申请公布号 US2014329847(A1) 申请公布日期 2014.11.06
申请号 US201414336753 申请日期 2014.07.21
申请人 ENDO PHARMACEUTICALS INC. 发明人 Ahdieh Harry
分类号 A61K31/485;A61K47/10;A61K47/02;A61K47/38;A61K47/36;A61K47/26 主分类号 A61K31/485
代理机构 代理人
主权项 1. A method of treating pain in a renally impaired patient comprising administering a pharmaceutical composition comprising about 5 mg to about 80 mg of oxymorphone or a pharmaceutically acceptable salt thereof as the sole active ingredient and a controlled release matrix, wherein the renally impaired patient is administered a dose of oxymorphone or a pharmaceutically acceptable salt thereof that is less than the dose administered to a comparable patient without renal impairment.
地址 Malvern PA US